Cook Jennifer E.
SEC Form 4 insider trading activity
Cook Jennifer E. has filed 6 SEC Form 4 filings (18 transaction rows) across 3 companies, including JAZZ, BBIO, DNLI, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Sep 2, 2026.
On the most recent filing, Cook Jennifer E. is listed as Director at BridgeBio Pharma, Inc. Inside the rolling window, Cook Jennifer E. reported no open-market purchases and 4 open-market sales totaling $21.9M in BBIO. The largest disclosed transaction in the window is a sale of 148,589 BBIO shares on Jul 9, 2026, worth $13.2M.
Companies traded
Other insiders at JAZZ
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$21.9M
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cook Jennifer E. made?
Cook Jennifer E. has filed 6 SEC Form 4 filings (18 transaction rows) across 3 companies, including JAZZ, BBIO, DNLI since 2026.
Which companies does Cook Jennifer E. trade?
Cook Jennifer E. has filed SEC Form 4 disclosures for 3 companies, including JAZZ, BBIO, DNLI.
When was Cook Jennifer E.'s most recent SEC Form 4 filing?
Cook Jennifer E.'s most recent SEC Form 4 filing on Tracefour is dated Sep 2, 2026.
What is Cook Jennifer E.'s total buy and sell value in the current window?
Inside the rolling retention window, Cook Jennifer E. bought $0 and sold $21.9M based on SEC Form 4 filings.
What was Cook Jennifer E.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 148,589 BBIO shares on 2026-07-09, worth $13.2M, per SEC Form 4 filings.